Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.66823 | 28 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.64437 | 28 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.54775 | 23 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.59043 | 28 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.70854 | 33 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.35113 | 52 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.39321 | 53 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.63226 | 28 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.58585 | 27 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.64561 | 29 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.86123 | 38 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.75038 | 34 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.62031 | 27 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.62105 | 27 |